StocksRunner logo
mail
search
 
menu
 
Elevance Health Inc.
412.38
-1.21%
 
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
 
 

ELV

 

Elevance Health Inc.

$412.38

 
-$5.05 | -1.21%
 
  Overview  
  
  Analysis  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
  
  Headlines  
 
 
52W High
$ 567.26
 
 
MKT CAP
$ 94.31B
 
52W Low
$ 362.21
 
 
VOL
$ 888.78K
 
P/E Ratio
N/A
 
 
AVG VOL
$ 1.72M
 
RSI
45.47
 
 
TREND
Sideways
 
 
 

Chart

 
 

432

391.6

371.07

519.19

 
 
1year
6month
3month
1month
 
ELV Latest Headlines +
 
 
 
StocksRunner

Explore our ELV Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored ELV Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our ELV Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
StocksRunner
 
 
StocksRunner
Overview
 
StocksRunner
Trending
 
StocksRunner
Screener
 
StocksRunner
Ideas
 
StocksRunner
Top Rated
 
StocksRunner
Momentum
 
StocksRunner
Earnings
 
 

Most Trending

 
 
 
Top Banner
 
  Overview  
  
  Analysis  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Earnings  
 
 
 
 
 
 

ELV

 

Elevance Health Inc.

$412.38

 
-$5.05 | -1.21%
 

 

Chart

 
 

432

391.6

371.07

519.19

 
 
1year
6month
3month
1month
 
 
 
 

ELV Latest Headlines

 
 
 

Elevance Health Inc. (ELV): Among the Best Stocks to Buy According to D1 Capitals Daniel Sundheim.

 

Tue Apr 29, 2025

 
Potential

ELV Factor-Based Stock Analysis. Below is Valideas guru fundamental report for ELEVANCE HEALTH INC (ELV). Of the 22 guru strategies we follow ELV rates highest using our Low PE Investor model based on the published strategy of John Neff. This strategy looks for firms with persistent earnings growth that trade

 

Wed Apr 23, 2025

 
Earnings

Elevance Health declares $1.71 dividend.

 

Wed Apr 23, 2025

 
Activity

Elevance Healths Q1 Earnings Beat Estimates on Rising Premiums. ELV continues to witness significant growth in Q1 revenues. However its operating costs surge.

 

Tue Apr 22, 2025

 
Earnings

Elevance health projects $34.15-$34.85 EPS for 2025 with focus on Carelon expansion.

 

Tue Apr 22, 2025

 
Activity

Despite Medicaid Pressure Elevance Health Delivers Strong Q1 Performance Reiterates Profit Outlook. ) on Tuesday reported first-quarter 2025 revenues of $48.77 billion up 15% year-over-year higher than the.The increase was driven by higher premium yields in the Health Benefits segment acquisitions completed in the past year Medicare Advantage and Individual ACA membership growth and CarelonRx product revenue partially offset by membership .The benefit expense ratio was 86.4% an increase of 80 ba

 

Tue Apr 22, 2025

 
Earnings

Elevance Health beats top-line and bottom-line estimates. reaffirms FY25 outlook.

 

Tue Apr 22, 2025

 
Earnings

Elevance Health Inc. Q1 Profit Beats Estimates . (RTTNews) - Elevance Health Inc. (ELV) reported a profit for first quarter that beat the Street estimates.

 

Tue Apr 22, 2025

 
Earnings

A Look Ahead: Elevance Healths Earnings Forecast. ) is set to give its latest quarterly earnings report on Tuesday 2025-04-22. Here'.s what investors need to know before the announcement.Analysts estimate that Elevance Health will report an Investors in Elevance Health are eagerly awaiting the company'.s announcement hoping for news of surpassing estimates and positive guidance for the next quarter.It'.s worth noting for new investors that stock prices can be heavily influenced by fu

 

Mon Apr 21, 2025

 
Earnings
Momentum
Potential

 
 
 
 
 
StocksRunner

Discover ELV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of ELV. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our ELV Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ELV Stock trends

ELV Stock performance

ELV Stock analysis

ELV investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 
Post ×
 
0/666
joker